Jaguar Health
JAGX
2 hedge funds and large institutions have $24.6K invested in Jaguar Health in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 6 closing their positions.
71% less funds holding
Funds holding: 7 → 2 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
91% less capital invested
Capital invested by funds: $283K → $24.6K (-$259K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$42.4K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8.48K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$97.7K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$60.1K |
| 3 |
HF
HRT Financial
New York
|
-$33K |
| 4 |
State Street
Boston,
Massachusetts
|
-$15.3K |
| 5 |
VF
Virtu Financial
New York
|
-$14K |
JAGX Hedge Fund Activity: Q1 2025 in Review
2 of the 7,477 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q1 2025, worth a combined $24.6K — down 91% from $283K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of JAGX and 1 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $42.4K. The largest seller was Geode Capital Management, exiting entirely with an estimated $97.7K sold.
- 2 institutional investors held Jaguar Health (JAGX) as of Q1 2025, down from 7 in Q4 2024.
- Funds reported $24.6K of Jaguar Health stock for Q1 2025, down 91% quarter-over-quarter.
- 1 fund opened new Jaguar Health positions in Q1 2025 and 6 closed out, a net change of -5 holders.
- The largest Jaguar Health buyer in Q1 2025 was UBS Group, an estimated $42.4K added.
- The largest Jaguar Health seller in Q1 2025 was Geode Capital Management, an estimated $97.7K sold.
Based on aggregated 13F filings for Q1 2025.